Overview
Navigating Changes in LDL Management: Focus on PCSK9 Inhibitors
Meeting Coverage from the CRT Conference 2017
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity.
The new cholesterol practice guidelines focus on measuring and treating cholesterol, and identifying whether someone already has or is at risk for ASCVD and could benefit from treatment (ie, individualizing treatments). Thus, risk assessment is essential and needs to be performed periodically. (Cardiosmart 2015) Stratifying patients by risk allows for appropriate medical therapy (ie, appropriate drug dosing). Statin intolerance also needs to be monitored in patients. If patients are deemed statin-resistant, alternative treatments exist and/or are emerging; these should be appropriately utilized to mitigate CVD risk. Yet, there are a number of unanswered questions with the latest guidelines and clinical application of new therapies that warrant addressing with education.
Upon completion of this activity, participants will be able to:
- Outline available lipid guidelines and the clinical implications
- Describe strategies to optimize lipid management in high-risk and other groups of patients to appropriately treat/mitigate CVD risk
- Formulate individual treatment regimens in patients who have not achieved reductions in LDL-C levels despite statin therapy
- Interpret the efficacy and safety data of available and emerging PCSK9 inhibitors and their role in current treatment paradigms
Clinical Professor of Medicine
Director, Preventive Cardiology
The University of Chicago Medicine
Chicago, IL
The following financial relationships have been provided:
The faculty may discuss investigational uses of biologics and other agents for LDL management.
This activity will take approximately 60 minutes to complete. To receive credit, participants are required to complete the pre-test, view the activity, and complete the post-test and evaluation. To receive credit, 75% must be achieved on the post-test. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
Inquiries may be directed to ACHL at (877) 444-8435, ext. 118.
The Academy for Continued Healthcare Learning (ACHL) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.